See every side of every news story

Published 2 days ago • loading... • Updated 2 days ago

Merck expands Welireg's use to broader set of kidney cancer patients

Summary by endpoints.news

Merck’s Welireg won FDA approval on Friday for use in combination with Eisai’s Lenvima to treat certain kidney cancer patients. The combination will be available to patients with advanced renal cell carcinoma with a clear ...

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

2 Articles

FDA Approves Welireg Plus Lenvima for Previously Treated Adult Patients With ccRCC

FDA has approved Welireg plus Lenvima for previously treated advanced clear cell renal cell carcinoma.

2 days ago

Read Full Article

Merck expands Welireg's use to broader set of kidney cancer patients

Merck’s Welireg won FDA approval on Friday for use in combination with Eisai’s Lenvima to treat certain kidney cancer patients. The combination will be available to patients with advanced renal cell carcinoma with a clear ...

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources2

Leaning Left0Leaning Right0Center0Last Updated2 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

endpoints.news broke the news 2 days ago on Friday, September 25, 2026.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics